EphA2 Immunoconjugate
Authors:
- 2 November 2012
- book chapter
- Published by Springer Nature
- p. 241-253
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Structure−Activity Relationship Analysis of Peptides Targeting the EphA2 ReceptorBiochemistry, 2010
- Direct assessment of P-glycoprotein efflux to determine tumor response to chemotherapyBiochemical Pharmacology, 2010
- EphA2 Immunoconjugate as Molecularly Targeted Chemotherapy for Ovarian CarcinomaJNCI: Journal of the National Cancer Institute, 2009
- Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptorOncogene, 2008
- Eph-Ephrin Bidirectional Signaling in Physiology and DiseaseCell, 2008
- The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcomeBritish Journal of Cancer, 2007
- Patterns of EphA2 protein expression in primary and metastatic pancreatic carcinoma and correlation with genetic statusClinical & Experimental Metastasis, 2006
- Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancerNature Genetics, 2004
- Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signalingNature Neuroscience, 2004
- Mechanisms and functions of eph and ephrin signallingNature Reviews Molecular Cell Biology, 2002